What is Biostatistical Analysis?
Biostatistical Analysis at API is a meticulous approach to extracting meaningful patterns and insights from complex life sciences data. We deploy advanced statistical methodologies to support decision making and ensure the validity and reliability of your findings.
Key Focus Areas:
- Statistical Analysis Plan and Study Design: Develop sound study designs that include sample size calculation to achieve sufficient statistical power, optimizing data collection and ensuring statistical validity.
- Data Analysis: Employ the most appropriate statistical techniques tailored to your study design to analyze data, uncover patterns, and draw meaningful conclusions.
- Clinical Trial Support: Provide critical statistical support throughout the lifecycle of clinical trials, from design to analysis and regulatory submissions.
Benefits of Biostatistical Analysis
Unlock the insights you’re seeking and experience the following benefits and more with our Biostatistical Analysis services:
- Data Accuracy: Ensure the accuracy and reliability of your results through rigorous statistical analysis and validation.
- Evidence-Based Decision-Making: Make informed decisions based on robust statistical evidence, enhancing the credibility of your research.
- Regulatory Compliance: Navigate regulatory requirements confidently with statistical analyses that meet industry standards and regulatory expectations.
- Risk Mitigation: Identify potential risks and challenges early in the research process, allowing for proactive mitigation strategies.
- Optimized Resource Allocation: Maximize the efficiency of your research efforts by strategically allocating resources based on statistical insights.
- Publication-Ready Results: Prepare results that are ready for publication in peer-reviewed journals, enhancing the visibility and impact of your research.
Biostatistical Analysis Team
VP, Quantitative SolutionsRead bioabout Patrick Mayo
VP, Quantitative Solutions
Dr. Mayo has over 40 years experience as a hospital clinical pharmacist and clinical pharmacologist in the pharmaceutical industry. He has worked at numerous biotech and CRO organizations integrating quantitative clinical pharmacology (pharmacometrics) with systems pharmacology, bioinformatics, and large data machine learning analytics. He was the Director of Clinical Pharmacology for Isotechnika Pharma, the SVP Clinical Pharmacology and Analytics for Hepion Pharma, and is the founder of Cogitare Analytics. In addition to quantitative analyses, Dr. Mayo also utilizes natural language processing to analyze texts, from antiquity to modern social media platforms.
Micheal Guirguis, PhD
Director, Clinical Pharmacology & DataRead bioabout Micheal Guirguis, PhD
Micheal Guirguis, PhD
Director, Clinical Pharmacology & Data
Micheal has over 20 years of experience as a pharmacokineticist and pharmacovigalence expert. During his career Micheal has worked for Alberta Health Services, Covance, Abbott, and Alberta Blue Cross and is a sought-after consultant for Health Canada and industry alike.
Quantitative Translational Pharmacologist
Quantitative Systems Pharmacologist
Morteza Hajihosseini, PhD MSc
Fernanda Talarico, MSc
Nastaran Hajizadeh Bastani
Want assistance with Biostatistical Analysis?
Let’s illuminate the path to more life sciences discoveries. Contact us to discuss how API’s Biostatistical Analysis services can elevate the statistical rigour of your research.
"*" indicates required fields
Combining scientific expertise, regulatory knowledge, and cutting-edge technology, API offers strategic support to…
Our clinical expertise at API spans pharmaceuticals and biologics, medical devices…
From strategy & planning to preparing regulatory filings, API provides guidance…